We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Test Drug Transfer Using Placenta-On-A-Chip

News   Feb 19, 2018 | Original story from University of Pennsylvania

 
Researchers Test Drug Transfer Using Placenta-On-A-Chip

The Huh lab's placenta-on-a-chip features two microfluidic channels that represent the maternal and fetal circulatory systems, and a membrane with living cells from the placental barrier that separates the two. There are few good options for testing how pharmaceuticals and other supplements might cross the placental barrier during pregnancy. Simulating that barrier on a chip, using human cells, is an alternative to inconclusive animal models, or using placental tissue donated after birth, which have a limited lifespan and require complicated experimental set-ups. Credit: University of Pennsylvania

 
 
Advertisement
 

RELATED ARTICLES

Could Heparin Be Used To Stop SARS-CoV-2 From Infecting Human Cells?

News

SARS-CoV-2 uses a surface spike protein to latch onto human cells and initiate infection. But, the drug heparin is capable of binding tightly to the same surface spike protein, potentially blocking the infection from happening.

READ MORE

Once-daily Topical Treatment Improves Chronic Plaque Psoriasis

News

In Phase 2b clinical trials, a once-daily roflumilast cream showed significant improvements in psoriasis signs and symptoms, in as early as two weeks.

READ MORE

Oncogene Responsible for Deadly Glioblastoma Identified

News

Scientists have identified an oncogene AVIL responsible for glioblastoma, the deadliest brain tumor. The discovery offers a promising new treatment target.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE